PATIENTS WITH ≥ 20 X 109/L PLATELETS AT BASELINE MAY HAVE A PROMPT RESPONSE TO ROMIPLOSTIM DURING THE EARLY PHASE OF TREATMENT: AN ITALIAN SINGLE-INSTITUTION EXPERIENCE by Simone Baldini, Luigi Rigacci, Valentina Carrai, Renato Alterini, Rajmonda Fjerza, Alberto Bosi

Subjects: Get full text

Effective treatment of refractory aplastic anemia with romiplostim after failure of multiple thrombopoietin receptor agonists: a single-center retrospective study by Xijuan Lin, Chen Yang, Ziwei Liu, Junling Zhuang, Miao Chen, Bing Han

Subjects: Get full text

Urogenital haemorrhage secondary to Babesia gibsoni induced immune thrombocytopenia and its management with combination of romiplostim and prednisolone in a dog by Nadima Khan, Anindita Sandilya, J. Kiran, Arindam Bhowmik, Gourav Debnath, Neeraj Thakur, H. Lalrinkima, Kalyan Sarma, Bedanga Konwar, G.E. Chethan

Subjects: Get full text

Romiplostim in thrombocytopenia treatment after allogeneic bone marrow transplantation by I. A. Lisukov, O. S. Uspenskaya, A. D. Kulagin, S. N. Bondarenko, T. A. Rudakova, O. A. Slesarchuk, B. V. Afanasyev

Subjects: “…romiplostim…”
Get full text

Evaluation of the Efficacy of Romiplostim in Management of Chemotherapy-Induced Thrombocytopenia in Indian Patients: A Retrospective Study by Vikas Talreja, Sangeeta Khatwani, Priyanka Subhagan

Subjects: Get full text

Pharmacoeconomic Analysis of the Use of Thrombopoietin Receptors Agonists in Idiopathic Thrombocytopenic Purpura Therapy by VA Shuvaev, SV Voloshin, AK Hadzhidis, AV Chechetkin

Subjects: Get full text

Results of long-term treatment with thrombopoietin receptor agonists of resistant primary immune thrombocytopenia by O. Yu. Vinogradova, M. M. Pankrashkina, L. A. Mukha, A. L. Neverova, M. V. Chernikov, V. V. Ptushkin

Subjects: Get full text

Thrombopoietin Receptor Agonists in Treatment of Idiopathic Thrompocytopenic Purpura (Primary Immune Thrombocytopenia): Efficacy and Safety in Everyday Clinical Practice by II Zotova, SV Gritsaev, ER Shilova, NA Potikhonova, KМ Abdulkadyrov, AV Chechetkin

Subjects: Get full text

Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim by Alessandro Pecci, Iman Ragab, Valeria Bozzi, Daniela De Rocco, Serena Barozzi, Tania Giangregorio, Heba Ali, Federica Melazzini, Mohamed Sallam, Caterina Alfano, Annalisa Pastore, Carlo L Balduini, Anna Savoia

Subjects: Get full text

Impact of Thrombopoietin Receptor Agonists on Pathophysiology of Pediatric Immune Thrombocytopenia by Paschalis Evangelidis, Konstantinos Tragiannidis, Eleni Gavriilaki, Athanasios Tragiannidis

Subjects: Get full text

Complications of thrombopoietin receptor agonists therapy in patients with immune thrombocytopenia by S. G. Zakharov, T. A. Mitina, A. V. Zakharova, O. P. Madzyara, I. N. Kontievskii, R. V. Vardanyan, E. V. Kataeva, Yu. B. Chernykh, L. L. Vysotskaya, L. V. Ivanitskiy, Yu. Yu. Chuksina, O. R. Zhuravlev, N. V. Gorgun, Z. M. Kharasova, E. V. Trifonova, K. A. Belousov, Z. R. Tekeeva

Subjects: Get full text

Management of patients with immune thrombocytopenia in the Moscow region by S. G. Zakharov, T. A. Mitina, R. V. Vardanyan, I. N. Kontievskiy, A. P. Faenko, Z. R. Tekeeva

Subjects: Get full text

The role of thrombopoietin receptor agonists in the management of adult primary immune thrombocytopenia: A single centre experience by Virijević Marijana, Mitrović Mirjana, Pantić Nikola, Pravdić Zlatko, Sabljić Nikica, Suvajdžić-Vuković Nada

Subjects: Get full text

SARS-COV-2 infection in a patient with Evans syndrome: A silent enemy or an ally? by Pantić Nikola, Mitrović Mirjana, Virijević Marijana, Sabljić Nikica, Pravdić Zlatko, Suvajdžić Nada

Subjects: Get full text

A multicenter mixed-methods study on the effects of intermittent fasting in patients with immune thrombocytopenia receiving thrombopoietin receptor agonists by Mohamed A. Yassin, Mohamed A. Yassin, Muna AlRasheed, Taghreed Al-Eisa, Noura Alhashim, Fiasal Alsayegh, Tarek E. Abouzeid, Mohamed Abd El Fattah, Maryam Alfili, Neveen Shalaby, Neveen Shalaby, Abdullah Alotaibi, Nourah Aljuwaisri, Anwar Almasbahi, Rii Saleeb, Hend Abdelaziz, Awni Alshurafa, Omar Ismail, Rola Ghasoub

Subjects: Get full text

Experience of 2^nd line therapy with eltrombopag in patients with immune thrombocytopenia by S. G. Zakharov, T. A. Mitina, R. V. Vardanyan, Z. R. Tekeeva, I. N. Kontievskiy, Yu. Yu. Chuksina, A. V. Zakharova

Subjects: Get full text

Thrombopoietin Receptor Agonists: Clinical Use and Evaluation of Treatment Efficacy by A. G. Solodovnikov, E. Yu. Sorokina, E. I. Morkovin

Subjects: Get full text

Clinical experience with romiplostim by G. B. Kuchma, L. K. Kozlova, Ye. Ye. Kuznetsova, S. B. Borisyuk

Subjects: Get full text

Tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in CML patients by V. A. Shuvaev, M. S. Fominykh, I. S. Martynkevich, V. Y. Udaleva, N. A. Potikhonova, M. N. Zenina, K. M. Abdulkadyrov

Subjects: Get full text

The Cost-Effectiveness of Avatrombopag Versus Eltrombopag and Romiplostim in the Treatment of Patients with Immune Thrombocytopenia in the UK by Nichola Cooper, Sebastian Guterres, Michał Pochopień, Koo Wilson, Sam James, Mondher Toumi, Anna Tytuła, Carly Rich, Daniel Eriksson

Subjects: Get full text